Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Ritonavir-boosted lopinavir as maintenance monotherapy in HIV-infected patients who achieved viral suppression during a second-line protease inhibitor-based regimen: a pilot randomized trial (BIDI-MONO).
J Int Assoc Provid AIDS Care. 2014 Jul-Aug;13(4):353-60. doi: 10.1177/2325957413511664.
J Int Assoc Provid AIDS Care. 2014.
PMID: 24378514
Free article.
Clinical Trial.
History of viral blip during virologic suppression with second-line PI-based regimen is a predictor of achieving viral suppression at all visits (adjusted relative risk 0.255 [95% confidence interval 0.080-0.821], P = .022). ...
History of viral blip during virologic suppression with second-line PI-based regimen is a predictor of achieving viral suppression at all …
Long-term outcomes of HIV-infected children in Thailand: the Thailand Pediatric HIV Observational Database.
Phongsamart W, Hansudewechakul R, Bunupuradah T, Klinbuayaem V, Teeraananchai S, Prasithsirikul W, Kerr SJ, Akarathum N, Denjunta S, Ananworanich J, Chokephaibulkit K.
Phongsamart W, et al.
Int J Infect Dis. 2014 May;22:19-24. doi: 10.1016/j.ijid.2013.12.011. Epub 2014 Feb 25.
Int J Infect Dis. 2014.
PMID: 24576843
Free article.
The death and lost to follow-up rates were 1.3 (95% confidence interval (CI) 1.1-1.6) and 2.2 (95% CI 1.6-2.6)/100 patient-years of follow-up, respectively. At the last clinic visit of 919 children, the median CD4 percentage was 27.0% (IQR 23.0-32.0%) and 80.2% had HIV-RNA …
The death and lost to follow-up rates were 1.3 (95% confidence interval (CI) 1.1-1.6) and 2.2 (95% CI 1.6-2.6)/100 patient-years of follow-u …
Item in Clipboard
Ritonavir-boosted lopinavir as maintenance monotherapy in HIV-infected patients who achieved viral suppression during a second-line protease inhibitor-based regimen: a pilot randomized trial (BIDI-MONO).
Siripassorn K, Chottanapund S, Prasithsirikul W, Manosuthi W.
Siripassorn K, et al.
J Int Assoc Provid AIDS Care. 2014 Jul-Aug;13(4):353-60.
J Int Assoc Provid AIDS Care. 2014.
PMID: 25513033
Clinical Trial.
History of viral blip during virologic suppression with second-line PI-based regimen is a predictor of achieving viral suppression at all visits (adjusted relative risk 0.255 [95% confidence interval 0.080-0.821], P = .022). ...
History of viral blip during virologic suppression with second-line PI-based regimen is a predictor of achieving viral suppression at all …
Item in Clipboard
Cite
Cite